isosorbide has been researched along with Heart Failure in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dong, W; Guo, J; Liu, CF; Qian, G; Wang, J | 1 |
| Drazner, MH; Wallace, TW | 1 |
| Branca, MA | 1 |
| Vivian, EM | 1 |
| Haughom, F; Kramer, B; Massie, BM | 1 |
| de Voogt, WG; Groeneveld, AB; Hoekstra, OS; Holman, ND; Schneider, AJ; van der Meer, J | 1 |
| Hori, M; Kamada, T; Lee, JM; Masuyama, T; Nagano, R; Nariyama, K; Tanouchi, J; Yamamoto, K | 1 |
| King, D | 1 |
| Benda, R; Cagin, NA; Levitt, B; Somberg, J | 1 |
| Iturriaga, J; Lanas, F; Opazo, JA; Saavedra, J; Salvatici, R | 1 |
| Bechler-Lisińska, J; Cholewa, M; Górski, L; Markiewicz, K | 1 |
| Bjornson, DC; Daniels, CE; Litman, TJ; Rector, TS; Snowdon, DA; Wertheimer, AI | 1 |
2 review(s) available for isosorbide and Heart Failure
| Article | Year |
|---|---|
The impact of race on response to RAAS inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Clinical Trials as Topic; Diuretics, Osmotic; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide; Vasodilator Agents; Ventricular Dysfunction, Left; White People | 2005 |
Diagnosis and management of heart failure in the elderly.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Diuretics; Female; Heart Failure; Humans; Hydralazine; Isosorbide; Male; Middle Aged; Prognosis; Vasodilator Agents | 1996 |
3 trial(s) available for isosorbide and Heart Failure
| Article | Year |
|---|---|
Prevention of contrast-induced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure.
Topics: Acute Kidney Injury; Aged; Aspirin; China; Contrast Media; Coronary Angiography; Double-Blind Method; Female; Fluid Therapy; Follow-Up Studies; Heart Failure; Humans; Incidence; Infusions, Intravenous; Isosorbide; Male; Prospective Studies; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2019 |
Acute effect of ibopamine and isosorbide mononitrate on blood volume distribution in congestive heart failure.
Topics: Aged; Blood Volume; Deoxyepinephrine; Double-Blind Method; Drug Interactions; Female; Heart Failure; Hemodynamics; Humans; Isosorbide; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Pentetate | 1994 |
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Captopril; Cardiac Output; Coronary Disease; Digoxin; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Furosemide; Heart Block; Heart Failure; Heart Valve Diseases; Heart Ventricles; Humans; Isosorbide; Male; Middle Aged; Nifedipine; Tachycardia; Vasodilator Agents | 1990 |
7 other study(ies) available for isosorbide and Heart Failure
| Article | Year |
|---|---|
BiDil raises questions about race as a marker.
Topics: Biomarkers; Black People; Clinical Trials as Topic; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Drug Approval; Drug Combinations; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Fluorouracil; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide; Middle Aged; Mutation; National Institutes of Health (U.S.); Polymorphism, Genetic; Quinazolines; Risk Factors; Socioeconomic Factors; Treatment Outcome; United States; Uracil; White People | 2005 |
Should drug therapy be personalized based on race?
Topics: Antihypertensive Agents; Black or African American; Diuretics; Drug Therapy; Ethnicity; Heart Failure; Humans; Hydralazine; Isosorbide; Minority Groups; Racial Groups; United States; White People | 2006 |
Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Exercise Test; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Isosorbide; Long-Term Care; Middle Aged; Oxygen Consumption; Rest; Time Factors; Vasodilator Agents | 1981 |
Effects of vasodilators on pulmonary venous and mitral flow velocity patterns in patients with congestive heart failure.
Topics: Adult; Aged; Blood Flow Velocity; Echocardiography, Doppler; Female; Heart Failure; Humans; Isosorbide; Male; Middle Aged; Mitral Valve; Mitral Valve Insufficiency; Myocardial Contraction; Nifedipine; Pulmonary Veins; Vasodilator Agents | 1993 |
Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual.
Topics: Administration, Oral; Adult; Aged; Female; Heart Failure; Humans; Isosorbide; Male; Middle Aged; Mouth Floor; Nitroglycerin; Sorbitol; Time Factors | 1978 |
[Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide; Isosorbide Dinitrate; Male; Middle Aged | 1979 |
Impact of a drug-use review program intervention on prescribing after publication of a randomized clinical trial.
Topics: Attitude of Health Personnel; Drug Prescriptions; Drug Utilization; Heart Failure; Hospitals, Veterans; Humans; Hydralazine; Information Theory; Isosorbide; Practice Patterns, Physicians'; Prazosin; Randomized Controlled Trials as Topic; Surveys and Questionnaires; United States | 1990 |